The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Urokinase Injection Market Research Report 2025
Synopsis
Urokinase, also known as urokinase-type plasminogen activator (uPA), is a serine protease present in humans and other animals. The human urokinase protein was discovered, but not named, by McFarlane and Pilling in 1947. Urokinase was originally isolated from human urine, and it is also present in the blood and in the extracellular matrix of many tissues. The primary physiological substrate of this enzyme is plasminogen, which is an inactive form (zymogen) of the serine protease plasmin.
The global Urokinase Injection market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Urokinase Injection is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Urokinase Injection is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Urokinase Injection include NDPHARM, Wanhua Biochem, Jiangxi Haoran Bio-Pharma, Jiangsu Aidea Pharmaceutical, Techpool, Microbic Biosystems Inc and LIVZON, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Urokinase Injection, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Urokinase Injection.
Report Scope
The Urokinase Injection market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Urokinase Injection market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Urokinase Injection manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
NDPHARM
Wanhua Biochem
Jiangxi Haoran Bio-Pharma
Jiangsu Aidea Pharmaceutical
Techpool
Microbic Biosystems Inc
LIVZON
Segment by Type
10000-100000IU
100000-1000000IU
Others
Segment by Application
Hospital
Clinic
Others
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Urokinase Injection manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Urokinase Injection in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Urokinase, also known as urokinase-type plasminogen activator (uPA), is a serine protease present in humans and other animals. The human urokinase protein was discovered, but not named, by McFarlane and Pilling in 1947. Urokinase was originally isolated from human urine, and it is also present in the blood and in the extracellular matrix of many tissues. The primary physiological substrate of this enzyme is plasminogen, which is an inactive form (zymogen) of the serine protease plasmin.
The global Urokinase Injection market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Urokinase Injection is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Urokinase Injection is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Urokinase Injection include NDPHARM, Wanhua Biochem, Jiangxi Haoran Bio-Pharma, Jiangsu Aidea Pharmaceutical, Techpool, Microbic Biosystems Inc and LIVZON, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Urokinase Injection, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Urokinase Injection.
Report Scope
The Urokinase Injection market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Urokinase Injection market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Urokinase Injection manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
NDPHARM
Wanhua Biochem
Jiangxi Haoran Bio-Pharma
Jiangsu Aidea Pharmaceutical
Techpool
Microbic Biosystems Inc
LIVZON
Segment by Type
10000-100000IU
100000-1000000IU
Others
Segment by Application
Hospital
Clinic
Others
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Urokinase Injection manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Urokinase Injection in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Urokinase Injection Market Overview
1.1 Product Overview and Scope of Urokinase Injection
1.2 Urokinase Injection Segment by Type
1.2.1 Global Urokinase Injection Market Value Comparison by Type (2024-2030)
1.2.2 10000-100000IU
1.2.3 100000-1000000IU
1.2.4 Others
1.3 Urokinase Injection Segment by Application
1.3.1 Global Urokinase Injection Market Value by Application: (2024-2030)
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Global Urokinase Injection Market Size Estimates and Forecasts
1.4.1 Global Urokinase Injection Revenue 2019-2030
1.4.2 Global Urokinase Injection Sales 2019-2030
1.4.3 Global Urokinase Injection Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Urokinase Injection Market Competition by Manufacturers
2.1 Global Urokinase Injection Sales Market Share by Manufacturers (2019-2024)
2.2 Global Urokinase Injection Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Urokinase Injection Average Price by Manufacturers (2019-2024)
2.4 Global Urokinase Injection Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Urokinase Injection, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Urokinase Injection, Product Type & Application
2.7 Urokinase Injection Market Competitive Situation and Trends
2.7.1 Urokinase Injection Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Urokinase Injection Players Market Share by Revenue
2.7.3 Global Urokinase Injection Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Urokinase Injection Retrospective Market Scenario by Region
3.1 Global Urokinase Injection Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Urokinase Injection Global Urokinase Injection Sales by Region: 2019-2030
3.2.1 Global Urokinase Injection Sales by Region: 2019-2024
3.2.2 Global Urokinase Injection Sales by Region: 2025-2030
3.3 Global Urokinase Injection Global Urokinase Injection Revenue by Region: 2019-2030
3.3.1 Global Urokinase Injection Revenue by Region: 2019-2024
3.3.2 Global Urokinase Injection Revenue by Region: 2025-2030
3.4 North America Urokinase Injection Market Facts & Figures by Country
3.4.1 North America Urokinase Injection Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Urokinase Injection Sales by Country (2019-2030)
3.4.3 North America Urokinase Injection Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Urokinase Injection Market Facts & Figures by Country
3.5.1 Europe Urokinase Injection Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Urokinase Injection Sales by Country (2019-2030)
3.5.3 Europe Urokinase Injection Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Urokinase Injection Market Facts & Figures by Country
3.6.1 Asia Pacific Urokinase Injection Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Urokinase Injection Sales by Country (2019-2030)
3.6.3 Asia Pacific Urokinase Injection Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Urokinase Injection Market Facts & Figures by Country
3.7.1 Latin America Urokinase Injection Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Urokinase Injection Sales by Country (2019-2030)
3.7.3 Latin America Urokinase Injection Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Urokinase Injection Market Facts & Figures by Country
3.8.1 Middle East and Africa Urokinase Injection Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Urokinase Injection Sales by Country (2019-2030)
3.8.3 Middle East and Africa Urokinase Injection Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Urokinase Injection Sales by Type (2019-2030)
4.1.1 Global Urokinase Injection Sales by Type (2019-2024)
4.1.2 Global Urokinase Injection Sales by Type (2025-2030)
4.1.3 Global Urokinase Injection Sales Market Share by Type (2019-2030)
4.2 Global Urokinase Injection Revenue by Type (2019-2030)
4.2.1 Global Urokinase Injection Revenue by Type (2019-2024)
4.2.2 Global Urokinase Injection Revenue by Type (2025-2030)
4.2.3 Global Urokinase Injection Revenue Market Share by Type (2019-2030)
4.3 Global Urokinase Injection Price by Type (2019-2030)
5 Segment by Application
5.1 Global Urokinase Injection Sales by Application (2019-2030)
5.1.1 Global Urokinase Injection Sales by Application (2019-2024)
5.1.2 Global Urokinase Injection Sales by Application (2025-2030)
5.1.3 Global Urokinase Injection Sales Market Share by Application (2019-2030)
5.2 Global Urokinase Injection Revenue by Application (2019-2030)
5.2.1 Global Urokinase Injection Revenue by Application (2019-2024)
5.2.2 Global Urokinase Injection Revenue by Application (2025-2030)
5.2.3 Global Urokinase Injection Revenue Market Share by Application (2019-2030)
5.3 Global Urokinase Injection Price by Application (2019-2030)
6 Key Companies Profiled
6.1 NDPHARM
6.1.1 NDPHARM Corporation Information
6.1.2 NDPHARM Description and Business Overview
6.1.3 NDPHARM Urokinase Injection Sales, Revenue and Gross Margin (2019-2024)
6.1.4 NDPHARM Urokinase Injection Product Portfolio
6.1.5 NDPHARM Recent Developments/Updates
6.2 Wanhua Biochem
6.2.1 Wanhua Biochem Corporation Information
6.2.2 Wanhua Biochem Description and Business Overview
6.2.3 Wanhua Biochem Urokinase Injection Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Wanhua Biochem Urokinase Injection Product Portfolio
6.2.5 Wanhua Biochem Recent Developments/Updates
6.3 Jiangxi Haoran Bio-Pharma
6.3.1 Jiangxi Haoran Bio-Pharma Corporation Information
6.3.2 Jiangxi Haoran Bio-Pharma Description and Business Overview
6.3.3 Jiangxi Haoran Bio-Pharma Urokinase Injection Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Jiangxi Haoran Bio-Pharma Urokinase Injection Product Portfolio
6.3.5 Jiangxi Haoran Bio-Pharma Recent Developments/Updates
6.4 Jiangsu Aidea Pharmaceutical
6.4.1 Jiangsu Aidea Pharmaceutical Corporation Information
6.4.2 Jiangsu Aidea Pharmaceutical Description and Business Overview
6.4.3 Jiangsu Aidea Pharmaceutical Urokinase Injection Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Jiangsu Aidea Pharmaceutical Urokinase Injection Product Portfolio
6.4.5 Jiangsu Aidea Pharmaceutical Recent Developments/Updates
6.5 Techpool
6.5.1 Techpool Corporation Information
6.5.2 Techpool Description and Business Overview
6.5.3 Techpool Urokinase Injection Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Techpool Urokinase Injection Product Portfolio
6.5.5 Techpool Recent Developments/Updates
6.6 Microbic Biosystems Inc
6.6.1 Microbic Biosystems Inc Corporation Information
6.6.2 Microbic Biosystems Inc Description and Business Overview
6.6.3 Microbic Biosystems Inc Urokinase Injection Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Microbic Biosystems Inc Urokinase Injection Product Portfolio
6.6.5 Microbic Biosystems Inc Recent Developments/Updates
6.7 LIVZON
6.6.1 LIVZON Corporation Information
6.6.2 LIVZON Description and Business Overview
6.6.3 LIVZON Urokinase Injection Sales, Revenue and Gross Margin (2019-2024)
6.4.4 LIVZON Urokinase Injection Product Portfolio
6.7.5 LIVZON Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Urokinase Injection Industry Chain Analysis
7.2 Urokinase Injection Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Urokinase Injection Production Mode & Process
7.4 Urokinase Injection Sales and Marketing
7.4.1 Urokinase Injection Sales Channels
7.4.2 Urokinase Injection Distributors
7.5 Urokinase Injection Customers
8 Urokinase Injection Market Dynamics
8.1 Urokinase Injection Industry Trends
8.2 Urokinase Injection Market Drivers
8.3 Urokinase Injection Market Challenges
8.4 Urokinase Injection Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of TablesList of Tables
Table 1. Global Urokinase Injection Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Urokinase Injection Market Value Comparison by Application (2024-2030) & (US$ Million)
Table 3. Global Urokinase Injection Market Competitive Situation by Manufacturers in 2023
Table 4. Global Urokinase Injection Sales (K Units) of Key Manufacturers (2019-2024)
Table 5. Global Urokinase Injection Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Urokinase Injection Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Urokinase Injection Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Urokinase Injection Average Price (US$/Unit) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Urokinase Injection, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Urokinase Injection, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Urokinase Injection, Product Type & Application
Table 12. Global Key Manufacturers of Urokinase Injection, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Urokinase Injection by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Urokinase Injection as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Urokinase Injection Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Urokinase Injection Sales by Region (2019-2024) & (K Units)
Table 18. Global Urokinase Injection Sales Market Share by Region (2019-2024)
Table 19. Global Urokinase Injection Sales by Region (2025-2030) & (K Units)
Table 20. Global Urokinase Injection Sales Market Share by Region (2025-2030)
Table 21. Global Urokinase Injection Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Urokinase Injection Revenue Market Share by Region (2019-2024)
Table 23. Global Urokinase Injection Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Urokinase Injection Revenue Market Share by Region (2025-2030)
Table 25. North America Urokinase Injection Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Urokinase Injection Sales by Country (2019-2024) & (K Units)
Table 27. North America Urokinase Injection Sales by Country (2025-2030) & (K Units)
Table 28. North America Urokinase Injection Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Urokinase Injection Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Urokinase Injection Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Urokinase Injection Sales by Country (2019-2024) & (K Units)
Table 32. Europe Urokinase Injection Sales by Country (2025-2030) & (K Units)
Table 33. Europe Urokinase Injection Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Urokinase Injection Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Urokinase Injection Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Urokinase Injection Sales by Region (2019-2024) & (K Units)
Table 37. Asia Pacific Urokinase Injection Sales by Region (2025-2030) & (K Units)
Table 38. Asia Pacific Urokinase Injection Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Urokinase Injection Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Urokinase Injection Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Urokinase Injection Sales by Country (2019-2024) & (K Units)
Table 42. Latin America Urokinase Injection Sales by Country (2025-2030) & (K Units)
Table 43. Latin America Urokinase Injection Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Urokinase Injection Revenue by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Urokinase Injection Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East & Africa Urokinase Injection Sales by Country (2019-2024) & (K Units)
Table 47. Middle East & Africa Urokinase Injection Sales by Country (2025-2030) & (K Units)
Table 48. Middle East & Africa Urokinase Injection Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa Urokinase Injection Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Urokinase Injection Sales (K Units) by Type (2019-2024)
Table 51. Global Urokinase Injection Sales (K Units) by Type (2025-2030)
Table 52. Global Urokinase Injection Sales Market Share by Type (2019-2024)
Table 53. Global Urokinase Injection Sales Market Share by Type (2025-2030)
Table 54. Global Urokinase Injection Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Urokinase Injection Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Urokinase Injection Revenue Market Share by Type (2019-2024)
Table 57. Global Urokinase Injection Revenue Market Share by Type (2025-2030)
Table 58. Global Urokinase Injection Price (US$/Unit) by Type (2019-2024)
Table 59. Global Urokinase Injection Price (US$/Unit) by Type (2025-2030)
Table 60. Global Urokinase Injection Sales (K Units) by Application (2019-2024)
Table 61. Global Urokinase Injection Sales (K Units) by Application (2025-2030)
Table 62. Global Urokinase Injection Sales Market Share by Application (2019-2024)
Table 63. Global Urokinase Injection Sales Market Share by Application (2025-2030)
Table 64. Global Urokinase Injection Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Urokinase Injection Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Urokinase Injection Revenue Market Share by Application (2019-2024)
Table 67. Global Urokinase Injection Revenue Market Share by Application (2025-2030)
Table 68. Global Urokinase Injection Price (US$/Unit) by Application (2019-2024)
Table 69. Global Urokinase Injection Price (US$/Unit) by Application (2025-2030)
Table 70. NDPHARM Corporation Information
Table 71. NDPHARM Description and Business Overview
Table 72. NDPHARM Urokinase Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 73. NDPHARM Urokinase Injection Product
Table 74. NDPHARM Recent Developments/Updates
Table 75. Wanhua Biochem Corporation Information
Table 76. Wanhua Biochem Description and Business Overview
Table 77. Wanhua Biochem Urokinase Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 78. Wanhua Biochem Urokinase Injection Product
Table 79. Wanhua Biochem Recent Developments/Updates
Table 80. Jiangxi Haoran Bio-Pharma Corporation Information
Table 81. Jiangxi Haoran Bio-Pharma Description and Business Overview
Table 82. Jiangxi Haoran Bio-Pharma Urokinase Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 83. Jiangxi Haoran Bio-Pharma Urokinase Injection Product
Table 84. Jiangxi Haoran Bio-Pharma Recent Developments/Updates
Table 85. Jiangsu Aidea Pharmaceutical Corporation Information
Table 86. Jiangsu Aidea Pharmaceutical Description and Business Overview
Table 87. Jiangsu Aidea Pharmaceutical Urokinase Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 88. Jiangsu Aidea Pharmaceutical Urokinase Injection Product
Table 89. Jiangsu Aidea Pharmaceutical Recent Developments/Updates
Table 90. Techpool Corporation Information
Table 91. Techpool Description and Business Overview
Table 92. Techpool Urokinase Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 93. Techpool Urokinase Injection Product
Table 94. Techpool Recent Developments/Updates
Table 95. Microbic Biosystems Inc Corporation Information
Table 96. Microbic Biosystems Inc Description and Business Overview
Table 97. Microbic Biosystems Inc Urokinase Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 98. Microbic Biosystems Inc Urokinase Injection Product
Table 99. Microbic Biosystems Inc Recent Developments/Updates
Table 100. LIVZON Corporation Information
Table 101. LIVZON Description and Business Overview
Table 102. LIVZON Urokinase Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 103. LIVZON Urokinase Injection Product
Table 104. LIVZON Recent Developments/Updates
Table 105. Key Raw Materials Lists
Table 106. Raw Materials Key Suppliers Lists
Table 107. Urokinase Injection Distributors List
Table 108. Urokinase Injection Customers List
Table 109. Urokinase Injection Market Trends
Table 110. Urokinase Injection Market Drivers
Table 111. Urokinase Injection Market Challenges
Table 112. Urokinase Injection Market Restraints
Table 113. Research Programs/Design for This Report
Table 114. Key Data Information from Secondary Sources
Table 115. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Urokinase Injection
Figure 2. Global Urokinase Injection Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Urokinase Injection Market Share by Type in 2023 & 2030
Figure 4. 10000-100000IU Product Picture
Figure 5. 100000-1000000IU Product Picture
Figure 6. Others Product Picture
Figure 7. Global Urokinase Injection Market Value Comparison by Application (2024-2030) & (US$ Million)
Figure 8. Global Urokinase Injection Market Share by Application in 2023 & 2030
Figure 9. Hospital
Figure 10. Clinic
Figure 11. Others
Figure 12. Global Urokinase Injection Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 13. Global Urokinase Injection Market Size (2019-2030) & (US$ Million)
Figure 14. Global Urokinase Injection Sales (2019-2030) & (K Units)
Figure 15. Global Urokinase Injection Average Price (US$/Unit) & (2019-2030)
Figure 16. Urokinase Injection Report Years Considered
Figure 17. Urokinase Injection Sales Share by Manufacturers in 2023
Figure 18. Global Urokinase Injection Revenue Share by Manufacturers in 2023
Figure 19. The Global 5 and 10 Largest Urokinase Injection Players: Market Share by Revenue in 2023
Figure 20. Urokinase Injection Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
Figure 21. Global Urokinase Injection Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 22. North America Urokinase Injection Sales Market Share by Country (2019-2030)
Figure 23. North America Urokinase Injection Revenue Market Share by Country (2019-2030)
Figure 24. United States Urokinase Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 25. Canada Urokinase Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 26. Europe Urokinase Injection Sales Market Share by Country (2019-2030)
Figure 27. Europe Urokinase Injection Revenue Market Share by Country (2019-2030)
Figure 28. Germany Urokinase Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 29. France Urokinase Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 30. U.K. Urokinase Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. Italy Urokinase Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 32. Russia Urokinase Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 33. Asia Pacific Urokinase Injection Sales Market Share by Region (2019-2030)
Figure 34. Asia Pacific Urokinase Injection Revenue Market Share by Region (2019-2030)
Figure 35. China Urokinase Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 36. Japan Urokinase Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. South Korea Urokinase Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. India Urokinase Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. Australia Urokinase Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. China Taiwan Urokinase Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. Indonesia Urokinase Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. Thailand Urokinase Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. Malaysia Urokinase Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 44. Latin America Urokinase Injection Sales Market Share by Country (2019-2030)
Figure 45. Latin America Urokinase Injection Revenue Market Share by Country (2019-2030)
Figure 46. Mexico Urokinase Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 47. Brazil Urokinase Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 48. Argentina Urokinase Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 49. Middle East & Africa Urokinase Injection Sales Market Share by Country (2019-2030)
Figure 50. Middle East & Africa Urokinase Injection Revenue Market Share by Country (2019-2030)
Figure 51. Turkey Urokinase Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 52. Saudi Arabia Urokinase Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 53. UAE Urokinase Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 54. Global Sales Market Share of Urokinase Injection by Type (2019-2030)
Figure 55. Global Revenue Market Share of Urokinase Injection by Type (2019-2030)
Figure 56. Global Urokinase Injection Price (US$/Unit) by Type (2019-2030)
Figure 57. Global Sales Market Share of Urokinase Injection by Application (2019-2030)
Figure 58. Global Revenue Market Share of Urokinase Injection by Application (2019-2030)
Figure 59. Global Urokinase Injection Price (US$/Unit) by Application (2019-2030)
Figure 60. Urokinase Injection Value Chain
Figure 61. Urokinase Injection Production Process
Figure 62. Channels of Distribution (Direct Vs Distribution)
Figure 63. Distributors Profiles
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
